Document is current
Any future updates will be listed below
-
Authors
Diaz-Torres, Santiago https://orcid.org/0000-0002-5442-9211
Lee, Samantha Sze-Yee https://orcid.org/0000-0001-6635-1098
García-Marín, Luis M. https://orcid.org/0000-0003-4731-6558
Campos, Adrian I. https://orcid.org/0000-0003-3468-8619
Lingham, Garreth https://orcid.org/0000-0002-8957-0733
Ong, Jue-Sheng https://orcid.org/0000-0002-6062-710X
Mackey, David A. https://orcid.org/0000-0001-7914-4709
Burdon, Kathryn P. https://orcid.org/0000-0001-8217-1249
Hunter, Michael https://orcid.org/0000-0001-6704-4815
Dong, Xianjun
MacGregor, Stuart https://orcid.org/0000-0001-6731-8142
Gharahkhani, Puya https://orcid.org/0000-0002-4203-5952
Rentería, Miguel E. https://orcid.org/0000-0003-4626-7248
- License Information
-
More Information
Article History
Received: 13 April 2023
Accepted: 2 October 2024
First Online: 23 October 2024
Competing interests
: A.I.C. is currently employed by the Regeneron Genetics Center, a wholly-owned subsidiary of Regeneron Pharmaceuticals, Inc., and may own Regeneron stock or stock options. A.I.C. contributed to this work during his tenure at QIMR Berghofer Medical Research Institute and The University of Queensland. The other authors report no competing interests.
: This study adheres to the principles of the Declaration of Helsinki and follows the guidelines set forth by the International Ethical Guidelines for Biomedical Research Involving Human Subjects. We are committed to promoting diversity and inclusivity in all aspects of its design, methodology, and analysis. We have striven to ensure that the sample population represents different ancestries to enhance the generalizability and relevance of our findings. We also acknowledge the importance of diverse perspectives in the interpretation of our results and have actively sought input from researchers and clinicians from varied backgrounds.
